Ironwood Pharmaceuticals | IRWD - Current Assets


Ironwood Pharmaceuticals reported $273.84M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Acadia Pharmaceuticals USD 1.06B 14.31M Dec/2025
Agios Pharmaceuticals USD 942.05M 91.06M Dec/2025
Akebia Therapeutics USD 252.96M 5.38M Dec/2025
Almirall EUR 713.98M 69K Dec/2025
Alnylam Pharmaceuticals USD 4.05B 97.85M Dec/2025
Amarin USD 649.88M 21.55M Dec/2025
Ardelyx USD 382.32M 14.33M Dec/2025
Astellas Pharma JPY 1.44T 72.43B Dec/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Charles River Laboratories USD 1.45B 85.06M Dec/2025
Coherus Biosciences USD 206.71M 254.25M Dec/2025
Emergent BioSolutions USD 679.5M 41.3M Dec/2023
Esperion Therapeutics USD 462.57M 102.11M Dec/2025
Halozyme Therapeutics USD 825.21M 503.54M Dec/2025
Incyte USD 5.02B 746.01M Dec/2025
Ironwood Pharmaceuticals USD 273.84M 82.09M Sep/2025
Karyopharm Therapeutics USD 103.15M 13.4M Dec/2025
Lexicon Pharmaceuticals USD 101.9M 20.63M Dec/2025
MacroGenics USD 219.94M 12.15M Dec/2025
Moderna USD 6.54B 54M Dec/2025
Myriad Genetics USD 332.6M 12.2M Dec/2025
Pacira USD 547.97M 14.78M Dec/2025
PTC Therapeutics USD 2.27B 266.14M Dec/2025
Puma Biotechnology USD 143.58M 7M Sep/2025
Sarepta Therapeutics USD 2.54B 184.37M Dec/2025
Takeda JPY 3.12T 195.82B Dec/2025
Ultragenyx Pharmaceutical USD 643.21M 76.58M Sep/2025
Vanda Pharmaceuticals USD 347.26M 20.23M Dec/2025